1020717-99-0

Basic information

• Product Name: 4-BROMO-5-FLUORO-2-NITROBENZOIC ACID
• Synonyms: 4-BROMO-5-FLUORO-2-NITROBENZOIC ACID
• CAS NO: 1020717-99-0
• Molecular Formula: C₇H₃BrFNO₄
• Molecular Weight: 264.0054232
• Mol File: 1020717-99-0.mol

Chemical Properties

• Boiling Point: 367.576 °C at 760 mmHg
• Flash Point: 176.104 °C
• Appearance: /
• Density: 1.967 g/cm³
• CAS DataBase Reference: 4-BROMO-5-FLUORO-2-NITROBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-5-FLUORO-2-NITROBENZOIC ACID(1020717-99-0)
• EPA Substance Registry System: 4-BROMO-5-FLUORO-2-NITROBENZOIC ACID(1020717-99-0)

Safety Data

• Hazardous Substances Data: 1020717-99-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-Bromo-5-fluoro-2-nitrobenzoic acid is used as a building block in organic synthesis for its ability to participate in a wide range of chemical reactions. Its unique substitution pattern allows for the creation of diverse chemical entities, facilitating the development of new compounds with specific properties.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Bromo-5-fluoro-2-nitrobenzoic acid is utilized as an intermediate in the production of various pharmaceuticals. Its reactivity and structural features contribute to the synthesis of drug candidates with potential therapeutic applications.
Used in Agrochemical Production:
4-Bromo-5-fluoro-2-nitrobenzoic acid is employed as a key intermediate in the synthesis of agrochemicals, including pesticides and herbicides. Its chemical properties enable the development of effective compounds for agricultural use, enhancing crop protection and yield.
Used in Dye Manufacturing:
4-Bromo-5-fluoro-2-nitrobenzoic acid is also used in the production of dyes, where its chemical structure contributes to the color and stability of the resulting dyes. Its versatility in chemical reactions allows for the creation of dyes with specific characteristics for various applications, such as textiles, inks, and plastics.

Upstream product

• 153556-42-4 4-bromo-3-fluorobenzoic acid 

Downstream Products

• 1220886-29-2 methyl 4-bromo-5-fluoro-2-nitrobenzoate 
• 1643368-58-4 BMS-986142 
• 1527490-64-7 4-bromo-5-methoxy-2-nitrobenzoic acid 
• 1374208-44-2 2,4-dichloro-6-fluoro-7-bromoquinazoline 
• 1374208-43-1 7-bromo-6-fluoro-1H-quinazoline-2,4-dione 
• 39978-90-0 4-bromo-5-hydroxy-2-nitrobenzoic acid 
• 83102-93-6 methyl 2-nitro-4-bromo-5-hydroxybenzoate 
• 1220886-73-6 C₈H₈BrNO₃*ClH 
• 1374208-42-0 3-fluoro-4-bromo-6-aminobenzoic acid 
• 1643156-18-6 4-bromo-2-hydrazinyl-5-fluorobenzoic acid monohydrochloride 
• 1395493-30-7 2-amino-4-bromo-5-fluorobenzoic acid methyl ester 
• 1446236-62-9 4-bromo-5-(2,4-difluorophenoxy)-2-(ethylsulfonamido)benzamide 
• 1446237-44-0 4-bromo-5-(2,4-difluorophenoxy)-2-(ethylsulfonamido)benzoic acid 

Relevant articles and documents

ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF

The disclosure relates to compounds that act as an allosteric inhibitors of epidermal growth factor receptor (EGFR); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.

SUBSTITUTED BENZAZINONES AS ANTIBACTERIAL COMPOUNDS

The present invention relates to LpxC antibacterial compounds of Formula (1A), corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions:, compound preparation, treatment methods and uses for bacterial infections, especially those caused by gram-negative bacteria.

Burton's tyrosine kinase inhibitor

The invention provides a Burton's tyrosine kinase inhibitor. Particularly, a compound capable of serving as the Btk inhibitor is obtained through a wide and thorough research. It is shown through experimental results that the compound has a good inhibitin

1,4-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND THEIR USE FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

The present invention provides a compound of formula IA or a pharmaceutically acceptable salt thereof; 5 (IA) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

TRICYCLIC SULFONAMIDE DERIVATIVES

The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of pain.

TRICYCLIC SULFONAMIDE DERIVATIVES

The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of pain.

SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS BROMODOMAIN INHIBITORS

The present invention provides novel substituted imidazo[4,5-c]quinoline derivatives of formula (1), which may be therapeutically useful, more particularly as Bromodomain inhibitors; (1) in which Cyi, Cy2, R1, R2/sub

VIRAL POLYMERASE INHIBITORS

The present application provides compounds of formula I wherein X, Y, R2, n, R5 and R6 are defined herein, useful as inhibitors of the hepatitis C virus NS5B polymerase The present application also provides pharmaceutical